Related references
Note: Only part of the references are listed.Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: A non-conventional hemolysin and a ribosomal RNA methyl transferase
Aejazur Rahman et al.
BMC BIOCHEMISTRY (2010)
Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of Mycobacterium tuberculosis Complex Isolates
Jakko van Ingen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
P. Jureen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates
Florence Brossier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome
Robin E. Stanley et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
Levan Jugheli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatment
Silke Feuerriegel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Thomas Schon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
Doris Hillemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Molecular Diagnostics in Tuberculosis Basis and Implications for Therapy
Seetha V. Balasingham et al.
MOLECULAR DIAGNOSIS & THERAPY (2009)
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis
M. Analise Zaunbrecher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2′-O-methylations in 16S and 23S rRNAs
Shanna K. Johansen et al.
MOLECULAR CELL (2006)
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology
Pontus Jureen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Molecular analysis of cross-resistance to capreomycin, kanamycin, arnikacin, and viomycin in Mycobacterium tuberculosis
CE Maus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis
CE Maus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis
A Krüüner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate
J Werngren et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
JC Camus et al.
MICROBIOLOGY-SGM (2002)
Share Paper
